Your browser doesn't support javascript.
loading
Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK.
Ng, Kenrick; Metcalf, Rob; Sacco, Joseph; Kong, Anthony; Wheeler, Graham; Forsyth, Sharon; Bhat, Reshma; Ward, Joseph; Ensell, Leah; Lowe, Helen; Spanswick, Victoria; Hartley, John; White, Laura; Lloyd-Dehler, Elizabeth; Forster, Martin.
Afiliación
  • Ng K; Medical Oncology, University College London, London, UK.
  • Metcalf R; Department of Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Sacco J; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Kong A; Comprehensive Cancer Centre, King's College London, London, UK.
  • Wheeler G; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Forsyth S; CR UK & UCL Cancer Trials Centre, University College London, London, UK.
  • Bhat R; CR UK & UCL Cancer Trials Centre, University College London, London, UK.
  • Ward J; Department of Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Ensell L; UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London, UK.
  • Lowe H; UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London, UK.
  • Spanswick V; UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London, UK.
  • Hartley J; UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London, UK.
  • White L; CR UK & UCL Cancer Trials Centre, University College London, London, UK.
  • Lloyd-Dehler E; PPI Representative, London, UK.
  • Forster M; UCL Cancer Institute, University College London, London, UK ctc.each@ucl.ac.uk.
BMJ Open ; 13(11): e070391, 2023 11 27.
Article en En | MEDLINE | ID: mdl-38011968
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello / Antineoplásicos Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello / Antineoplásicos Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido